# Aurobindo Pharma Ltd – FDA Inspection, Aug 10, 2018

Source: https://www.keypedia.com/records/fda_inspections/aurobindo-pharma-ltd/d05b0a30-90c9-4d0a-838e-86b02662c9d4
Source feed: FDA_Inspections

> FDA inspection 1061698 of Aurobindo Pharma Ltd, August 10, 2018. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 314. Form 483 issued. 11 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1061698
- Company Name: Aurobindo Pharma Ltd
- Inspection Date: 2018-08-10
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Postmarket Surv. and Epidemiology
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Documents

- [FDA Inspection 1210950 - 2023-07-21](https://www.keypedia.com/records/fda_inspections/aurobindo-pharma-ltd/456ed1f7-cbc3-4ed8-a484-85c4b018e2fa)
- FDA Inspection 1155879 - 2019-07-05
- [FDA Inspection 1090627 - 2019-05-24](https://www.keypedia.com/records/fda_inspections/aurobindo-pharma-ltd/e3cd1f8d-155d-4a10-b7f7-2443f3cc028c)
- [FDA Inspection 1010385 - 2017-04-18](https://www.keypedia.com/records/fda_inspections/aurobindo-pharma-ltd/83bc7209-2966-4c8d-84a1-86ccb14266cc)
- FDA Inspection 960797 - 2016-01-29

## Related Officers

- [Company Rep](https://www.keypedia.com/people/courtney-n-long/32118415-bc77-4ac2-8f90-947e43cf10ff)
- [Company Rep](https://www.keypedia.com/people/jennifer-c-adams/85608566-bd13-41d8-b86e-cc9111c7dfe5)

Company: https://www.keypedia.com/companies/aurobindo-pharma-ltd/169fdedf-28b5-446b-84f4-65ca9bc54a1a

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c